These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7500543)

  • 1. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction.
    Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H
    Jpn Circ J; 1995 Sep; 59(9):599-607. PubMed ID: 7500543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [123I-MIBG myocardial scintigraphy in diabetic patients: association with autonomic neuropathy].
    Nagamachi S; Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
    Kaku Igaku; 1994 Sep; 31(9):1059-69. PubMed ID: 7967189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
    Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
    J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.
    Nagamachi S; Jinnouchi S; Kurose T; Ohnishi T; Flores LG; Nakahara H; Futami S; Tamura S; Matsukura S
    Ann Nucl Med; 1998 Dec; 12(6):323-31. PubMed ID: 9972369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability.
    Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T
    Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy.
    Nagamachi S; Jinnouchi S; Nakahara H; Flores LG; Ohnishi T; Hoshi H; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
    Nucl Med Commun; 1996 Jul; 17(7):621-32. PubMed ID: 8843123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine.
    Kim SJ; Lee JD; Ryu YH; Jeon P; Shim YW; Yoo HS; Park CY; Lim SG
    Eur J Nucl Med; 1996 Apr; 23(4):401-6. PubMed ID: 8612660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
    Langer A; Freeman MR; Josse RG; Armstrong PW
    J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.
    Schnell O; Kirsch CM; Stemplinger J; Haslbeck M; Standl E
    Diabetologia; 1995 Nov; 38(11):1345-52. PubMed ID: 8582545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction.
    Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H
    J Nucl Cardiol; 1996; 3(6 Pt 1):508-15. PubMed ID: 8989675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic cardiac autonomic dysfunction: parasympathetic versus sympathetic.
    Uehara A; Kurata C; Sugi T; Mikami T; Shouda S
    Ann Nucl Med; 1999 Apr; 13(2):95-100. PubMed ID: 10355953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional abnormality of iodine-123-MIBG in diabetic hearts.
    Hattori N; Tamaki N; Hayashi T; Masuda I; Kudoh T; Tateno M; Tadamura E; Yonekura Y; Nakao K; Konishi J
    J Nucl Med; 1996 Dec; 37(12):1985-90. PubMed ID: 8970519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
    Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M
    J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of myocardial imaging by 123I-MIBG in assessment of diabetic neuropathy].
    Katono E; Owada K; Takeda H; Techigawara M; Watanabe N; Maruyama Y
    Kaku Igaku; 1993 Oct; 30(10):1235-9. PubMed ID: 8264114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder].
    Hakusui S; Yasuda T; Yanagi T; Takahashi A; Hasegawa Y; Inoue M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):402-4. PubMed ID: 8026141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.
    Langen KJ; Ziegler D; Weise F; Piolot R; Boy C; Hübinger A; Gries FA; Müller-Gärtner HW
    Clin Sci (Lond); 1997 Oct; 93(4):325-33. PubMed ID: 9404224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.
    Mäntysaari M; Kuikka J; Mustonen J; Tahvanainen K; Vanninen E; Länsimies E; Uusitupa M
    Clin Auton Res; 1996 Jun; 6(3):163-9. PubMed ID: 8832126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy.
    Lanza GA; Giordano A; Pristipino C; Calcagni ML; Meduri G; Trani C; Franceschini R; Crea F; Troncone L; Maseri A
    Circulation; 1997 Aug; 96(3):821-6. PubMed ID: 9264488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic assessment of silent myocardial ischaemia after early infarction using myocardial SPET imaging with 201Tl and 123I-MIBG.
    Shimonagata T; Ishida Y; Hayashida K; Takamiya M; Uehara T; Nishimura T
    Nucl Med Commun; 1995 Nov; 16(11):893-900. PubMed ID: 8587753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.